Get started
Author

Apostolia Papalexandri

Observed names: A Papalexandri, A. Papalexandri, Papalexandri A
OpenAlex ID: A5014990774
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
2022 · Panagiotis G. Asteris, Eleni Gavriilaki, et al. · Journal of Cellular and Molecular Medicine · 92
PDF
Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy
2019 · Eleni Gavriilaki, Akrivi Chrysanthopoulou, et al. · Thrombosis and Haemostasis · 67
Genetic justification of severe COVID-19 using a rigorous algorithm
2021 · Eleni Gavriilaki, Panagiotis G. Asteris, et al. · Clinical Immunology · 64
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study
2018 · Ioanna Sakellari, Eleni Gavriilaki, et al. · Journal of Clinical Apheresis · 49
Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy
2020 · Eleni Gavriilaki, Tasoula Touloumenidou, et al. · Thrombosis and Haemostasis · 47
In vitro evidence of complement activation in patients with sickle cell disease
2017 · Eleni Gavriilaki, Maria Mainou, et al. · Haematologica · 40
Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation
2020 · Eleni Gavriilaki, Ioanna Sakellari, et al. · HemaSphere · 38
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation
2016 · Ioanna Sakellari, Despina Mallouri, et al. · Transplantation and Cellular Therapy · 37
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
2023 · Anastasia Papadopoulou, George Karavalakis, et al. · Nature Medicine · 36
Extracorporeal photopheresis in refractory chronic graft-versus-host disease: The influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology
2011 · Panagiotis Tsirigotis, Violetta Kapsimalli, et al. · Transfusion and Apheresis Science · 23
Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?
2018 · Apostolia Papalexandri, Riad Saloum, et al. · HemaSphere · 22
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease
2019 · Eleni Gavriilaki, Ioanna Sakellari, et al. · International Journal of Hematology · 20
Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML
2021 · Chrysavgi Lalayanni, Eleni Gavriilaki, et al. · Clinical Lymphoma Myeloma & Leukemia · 17
Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: A study by the Hellenic association of hematology
2011 · Panagiotis Tsirigotis, Panayotis Kaloyannidis, et al. · Transfusion and Apheresis Science · 17
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
2023 · Glykeria Gkoliou, Andreas Agathangelidis, et al. · Frontiers in Oncology · 14
Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection
2022 · Eleni Gavriilaki, Stefanos A. Tsiftsoglou, et al. · Current Issues in Molecular Biology · 13
PDF
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
2022 · Eleni Gavriilaki, Dimitra Dalampira, et al. · Journal of Clinical Medicine · 13
PDF
Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection
2023 · Stefanos A. Tsiftsoglou, Eleni Gavriilaki, et al. · Immunobiology · 12
PDF
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients
2022 · Eleni Gavriilaki, Anastasia Papadopoulou, et al. · Bone Marrow Transplantation · 12
PDF
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients
2024 · Eleni Gavriilaki, Christos Demosthenous, et al. · International Journal of Molecular Sciences · 10
PDF
Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center
2022 · Christos Varelas, Eleni Gavriilaki, et al. · Journal of Clinical Medicine · 10
PDF
Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies
2021 · Ioanna Sakellari, Eleni Gavriilaki, et al. · Transplantation and Cellular Therapy · 10
Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study
2024 · Theodora-Maria Venou, Evangelia Vetsiou, et al. · Journal of Personalized Medicine · 9
PDF
Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes
2022 · Chrysavgi Lalayanni, Christos Demosthenous, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?
2019 · Apostolia Papalexandri, Maria Karypidou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Works count: 89
Citation count: 816
H-index: 14
I10-index: 22
Year
Topic
Type